The mechanism through which [NSIS6S]-[NSIS]5 impacts on tumor angiogenesis is different from VEGF inhibitors which reduce vessel formation and increase vessel maturity but without affecting vessel size and lumen formation, which we observed with the dodecasaccharide. The gene discussed is VEGFA; the disease is neoplasm.